Dr. Julien M.NYOMBAYIRE

Dr. Julien NYOMBAYIRE is a distinguished researcher and academic known for his extensive work in infectious diseases, reproductive health, and public health interventions. His recent publications reflect a strong focus on vaccine safety and efficacy, particularly in the context of Ebola, as well as the implementation of family planning programs and the study of sexual health among marginalized communities in Rwanda.
Dr. Nyombayire’s latest work, “Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign,” published in the Journal of Infectious Diseases in 2023, underscores his commitment to advancing vaccine research and public health safety.
His research on the safety, reactogenicity, and immunogenicity of the Ebola vaccine regimen in pregnant women, published in Trials in 2022, further highlights his dedication to vulnerable populations. In addition to his work on infectious diseases, Dr. Nyombayire has made significant contributions to reproductive health. His studies on postpartum family planning programs and the uptake of long-acting contraceptives in Rwanda, published in journals such as Trials, PLoS ONE, and BMJ Sexual and Reproductive Health, demonstrate his expertise in implementing and evaluating large-scale health interventions.
Dr. Nyombayire has also explored the intersection of sexual behavior stigma and mental health among men who have sex with men and transgender women in Kigali, Rwanda. His research, published in the International Journal of Mental Health and Addiction and Sexually Transmitted Infections, provides valuable insights into the determinants of sexually transmitted infections and the mental health challenges faced by these communities.
Throughout his career, Dr. Nyombayire has received support from prestigious institutions, including the National Institute of Allergy and Infectious Diseases, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Bill and Melinda Gates Foundation. His work has also been backed by the United States Agency for International Development, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Mental Health, the International AIDS Vaccine Initiative, and the Emory Center for AIDS Research.
Dr. Nyombayire’s contributions to public health, infectious disease research, and reproductive health have had a profound impact on health outcomes in Rwanda and beyond. His dedication to improving health services and addressing the needs of marginalized populations continues to drive his research and advocacy efforts.